David D Chang insider trades

Open-market stock purchases and sales by David D Chang, President and CEO at Allogene Therapeutics, Inc, from SEC Form 4 filings since Jun 25, 2014.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -93%.

Recent trades

DateStockTradeValue
Mar 16, 2026ALLO Allogene Therapeutics, IncSold$118K
Feb 2, 2026ALLO Allogene Therapeutics, IncSold$171K
Feb 2, 2026ALLO Allogene Therapeutics, IncBought (not open market)—
Feb 2, 2026ALLO Allogene Therapeutics, IncBought (not open market)—

Companies traded

  • ALLO Allogene Therapeutics, Inc: 1 buy, 8 sales, last Mar 16, 2026
  • KITE Kite Pharma, Inc: 1 buy, 31 sales, last Oct 3, 2017

Get free alerts when David D Chang files a new trade →